Author

K. Purves

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

R. Haverty· 3 shared A. Fabre· 2 shared J. McCormack· 2 shared N. Fletcher· 2 shared P. W. Mallon· 2 shared S. O'Reilly· 2 shared V. Gautier· 2 shared A. Ryan· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

R. Haverty

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system

R. Haverty, J. McCormack, C. Evans, K. Purves, S. O'Reilly, V. W. Gautier, K. Rochfort, A. Fabre, N. Fletcher

This study shows SARS-CoV-2 can infect neurons, astrocytes, choroid plexus epithelial cells, and pericytes in the human central nervous system, supporting a model of direct viral infection as a cause of neurological symptoms in COVID-19.

bioRxiv · Nov 21, 2023 · PreprintMicrobiology

First Eurasian cases of SARS-CoV-2 seropositivity in a free-ranging urban population of wild fallow deer

K. Purves, H. Brown, R. Haverty, A. Ryan, L. Griffin, J. McCormack, S. R. O'Reilly, P. W. Mallon, V. Gautier, J. P. Cassidy, A. Fabre, M. J. Carr, G. Gonzalez, S. Ciuti, N. Fletcher

The paper reports the first cases of SARS-CoV-2 seropositivity in Eurasian fallow deer, showing increased seroprevalence with emerging variants.

bioRxiv · Jul 7, 2023 · PreprintMicrobiology

A novel antiviral formulation inhibits SARS-CoV-2 infection of human bronchial epithelium

K. Purves, R. Haverty, T. O'Neill, D. Folan, S. O'Reilly, A. W. Baird, D. Scholz, P. W. Mallon, V. Gautier, M. Folan, N. F. Fletcher

This study demonstrates that ViruSAL inhibits SARS-CoV-2 infection in human bronchial epithelial cells and rat models without causing toxicity.

bioRxiv · Oct 5, 2022 · PreprintPharmacology & Toxicology